Although there are more than 100 conditions that fall under the umbrella term "arthritis," an autoimmune disease called rheumatoid arthritis is one of the more common. According to the Arthritis ...
The RA latex turbid test helps diagnose rheumatoid arthritis (RA) and other autoimmune diseases by detecting rheumatoid factor (RF) in the blood. A higher-than-normal result on the RA latex turbid ...
Findings being presented in San Francisco show which patients may be able to stop anti-TNF therapy, and which ones will do well with conventional drugs as second-line treatment. A test that predicts ...
While the emergence of new antirheumatic agents—including biologics—has revolutionized the treatment of rheumatoid arthritis (RA), these drugs come a high cost to the healthcare system.
Oct. 28, 2003 (Orlando) -- The presence of antibodies to cyclic citrullinated peptides (CCP) may accurately predict the likelihood of developing rheumatoid arthritis (RA) in patients with recent-onset ...
Researchers have identified several cytokines, cytokine-related factors, and chemokines that increase significantly prior to rheumatoid arthritis disease onset. These findings confirm those of earlier ...
Equipped with a blood test capable of predicting an individual’s response—or lack thereof—to the world’s largest drug class, Scipher Medicine is on its way to cracking the code of rheumatoid arthritis ...
Exagen Diagnostics has announced the launch of the first validated blood test to detect anticarbamylated protein antibodies, which have been found to be significantly elevated in patients with ...
Lake Charles, LA (KPLC) - Rheumatoid arthritis is a progressive autoimmune disease that if left untreated, can attack the joints and internal organs. There are medications that can help block the ...
Oxford University researchers have devised a blood test that can predict the chance of developing rheumatoid arthritis up to 16 years before its onset. The blood test created by the team, writing in ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results